This is a routine administrative filing for an expired warrant series. No action required — monitor for any subsequent filings regarding the common stock listing status.
Price Chart
Executive Summary
Nasdaq filed a Form 25-NSE to remove from listing and deregister SAB Biotherapeutics' warrants expiring October 22, 2026, under SEC Rule 12d2-2(a)(2) (matured/expired securities). This is an administrative delisting of an expired warrant series, not the common stock. The filing has no impact on the company's ongoing listing status or operations.
Key Facts
- Form 25-NSE filed by Nasdaq Stock Market LLC to delist and deregister SAB Biotherapeutics' warrants expiring 10/22/2026
- Delisting is under SEC Rule 12d2-2(a)(2) for matured, redeemed, or retired securities
- The filing does not affect SAB Biotherapeutics' common stock listing
- Effectiveness date is October 22, 2026
Financial Impact
No financial impact — delisting of expired warrants only
Risk Factors
- None from this filing; warrants have already expired
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-001016 |
| Document: 0001354457-26-001016-index-headers.html | 0001354457-26-001016 |
| Document: 0001354457-26-001016-index.html | 0001354457-26-001016 |
| Document: 0001354457-26-001016.txt | 0001354457-26-001016 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 25-NSE | $2.84 | awaiting T+5 | — | $3.07 (+7.92%) |
Oct 13, 2026 14d ago | 8-K | $2.68 $2.88 | ▲ +7.46% | ▲ +8.61% | $3.07 (+14.37%) |
Oct 13, 2026 14d ago | Press Release | $2.68 $2.88 | ▲ +7.46% | ▲ +8.61% | $3.07 (+14.37%) |
Jul 7, 2026 16w ago | 8-K | $3.90 $3.60 | ▼ −7.69% | ▼ −8.24% | $3.07 (−21.41%) |
May 29, 2026 21w ago | Press Release | $3.60 $3.36 | ▼ −6.67% | ▼ −6.37% | $3.07 (−14.86%) |
May 12, 2026 24w ago | Press Release | $3.62 $3.56 | ▲ +1.66% | ▲ +1.74% | $3.07 (+15.33%) |
Mar 19, 2026 31w ago | Press Release | $3.75 $3.85 | ▲ +2.67% | ▲ +4.82% | $3.07 (−18.27%) |
Mar 19, 2026 31w ago | 8-K | $3.78 $3.83 | ▼ −1.32% | ▼ −3.53% | $3.07 (+18.92%) |
Mar 17, 2026 31w ago | Press Release | $3.70 $3.82 | ▼ −3.24% | ▼ −3.96% | $3.07 (+17.16%) |
Mar 17, 2026 31w ago | Press Release | $3.70 $3.82 | ▼ −3.24% | ▼ −3.96% | $3.07 (+17.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers